However, in the context of MM, LY9 is overexpressed on malignant plasma cells across various disease stages, including monoclonal gammopathy of undetermined significance (MGUS), smoldering MM, MM, extramedullary MM, and plasma cell leukemia [152, 153]. Here, LY9 is linked to Miyoshi myopathy.